966 related articles for article (PubMed ID: 20729457)
21. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
[TBL] [Abstract][Full Text] [Related]
22. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
[TBL] [Abstract][Full Text] [Related]
23. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
[TBL] [Abstract][Full Text] [Related]
24. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
26. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.
Park Y; Choi D; Lim HK; Rhim H; Kim YS; Kim SH; Lee WJ
AJR Am J Roentgenol; 2008 Jul; 191(1):215-20. PubMed ID: 18562748
[TBL] [Abstract][Full Text] [Related]
27. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
28. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.
Nakazawa T; Kokubu S; Shibuya A; Ono K; Watanabe M; Hidaka H; Tsuchihashi T; Saigenji K
AJR Am J Roentgenol; 2007 Feb; 188(2):480-8. PubMed ID: 17242258
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
31. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
[TBL] [Abstract][Full Text] [Related]
32. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
33. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
[TBL] [Abstract][Full Text] [Related]
34. Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.
Francica G; Petrolati A; Di Stasio E; Pacella S; Stasi R; Pacella CM
Acta Radiol; 2012 May; 53(4):394-400. PubMed ID: 22393158
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
37. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
